New Issue | Current HIV Research; Volume 18 Issue 2

chivr-2020

 

AIMS & SCOPE

Current HIV Research covers all the latest and outstanding developments of HIV research by publishing original research, full-length/mini review articles and guest edited thematic issues. The novel pioneering work in the basic and clinical fields on all areas of HIV research covers: virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, social and public health issues related to HIV disease, and prevention of viral infection. Periodically, the journal invites guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.

 

 

Articles from the Journal: Current HIV Research; Volume 18 Issue 2

 

 

FOR DETAILS ON THE ARTICLES, PLEASE VISIT HERE 

Editors Choice Article | Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID Workshop

Journal Name: Current HIV Research

Author(s): Ramesh Akkina, Daniel L. Barber, Moses T. Bility, Karl-Dimiter Bissig, Benjamin J. Burwitz, Katrin Eichelberg, Janice J. Endsley, J. Victor Garcia, Richard Hafner, Petros C. Karakousis, Brent E. Korba, Rajen Koshy, Chris Lambros, Stephan Menne, Eric L. Nuermberger, Alexander Ploss, Brendan K. Podell, Larisa Y. Poluektova, Brigitte E. Sanders-Beer*, Selvakumar Subbian, Angela Wahl.

 

 

 

Graphical Abstract:

0x3

 

 

Abstract:

The main advantage of animal models of infectious diseases over in vitro studies is the gain in the understanding of the complex dynamics between the immune system and the pathogen. While small animal models have practical advantages over large animal models, it is crucial to be aware of their limitations. Although the small animal model at least needs to be susceptible to the pathogen under study to obtain meaningful data, key elements of pathogenesis should also be reflected when compared to humans. Welldesigned small animal models for HIV, hepatitis viruses and tuberculosis require, additionally, a thorough understanding of the similarities and differences in the immune responses between humans and small animals and should incorporate that knowledge into the goals of the study. To discuss these considerations, the NIAID hosted a workshop on ‘Small Animal Models for HIV, Hepatitis B, and Tuberculosis’ on May 30, 2019. Highlights of the workshop are outlined below.

 

To read out more, please visit: http://www.eurekaselect.com/177698/article

World Aids Day, 2019!

world-aids-day-.jpg

Bentham Science Publish articles related to WORLD AIDS DAY in its subscription based journals including: 

 

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume 5, Issue 1, February, 2006 – Volume 18, Issue 2, September, 2019


Current HIV Research
Volume 1, Issue 1, January, 2003 – Volume 17, Issue 5, September, 2019


Current Immunology Reviews
Volume 1, Issue 1, January, 2005 – Volume 15, Issue 2, August, 2019

 

Endocrine, Metabolic & Immune Disorders – Drug Targets
Volume 6, Issue 1, March, 2006 – Volume 19, Issue 8, December, 2019


Recent Patents on Inflammation & Allergy Drug Discovery
Volume 1, Issue 1, February, 2007 – Volume 13, Issue 2, October, 2019

For eBooks, Please find the link HERE consisting of all the relevant eBooks and avail 30% DISCOUNT OFFER on related Books!

 

 

Aims & Scope | Current HIV Research

Aims & Scope

Current HIV Research covers all the latest and outstanding developments of HIV research by publishing original research, review articles and guest edited thematic issues. The novel pioneering work in the basic and clinical fields on all areas of HIV research covers: virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, social and public health issues related to HIV disease, and prevention of viral infection. Periodically, the journal invites guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.

 

chivr-flyer

 

Read out more at: https://benthamscience.com/journals/current-hiv-research/aims-scope/#top

Most Accessed Articles | Structural Barriers to Pre-exposure Prophylaxis Use Among Young Sexual Minority Men: The P18 Cohort Study

Journal Name: Current HIV Research

Author(s): Jessica Jaiswal*, Marybec Griffin, Stuart N. Singer, Richard E. Greene, Ingrid Lizette Zambrano Acosta, Saara K. Kaudeyr, Farzana Kapadia, Perry N. Halkitis.

 

 

Graphical Abstract:

 

Abstract:

Background: Despite decreasing rates of HIV among many populations, HIV-related health disparities among gay, bisexual and other men who have sex with men persist, with disproportional percentages of new HIV diagnoses among racial and ethnic minority men. Despite increasing awareness of HIV pre-exposure prophylaxis (PrEP), PrEP use remains low. In addition to exploring individual-level factors for this slow uptake, structural drivers of PrEP use must also be identified in order to maximize the effectiveness of biomedical HIV prevention strategies.

Method: Using cross-sectional data from an ongoing cohort study of young sexual minority men (N=492), we examine the extent to which structural-level barriers, including access to health care, medication logistics, counseling support, and stigma are related to PrEP use.

Results: While almost all participants indicated awareness of PrEP, only 14% had ever used PrEP. PrEP use was associated with lower concerns about health care access, particularly paying for PrEP. Those with greater concerns talking with their provider about their sexual behaviors were less likely to use PrEP.

Conclusion: Paying for PrEP and talking to one’s provider about sexual behaviors are concerns for young sexual minority men. In particular, stigma from healthcare providers poses a significant barrier to PrEP use in this population. Providers need not only to increase their own awareness of and advocacy for PrEP as an effective risk-management strategy for HIV prevention, but also must work to create open and non-judgmental spaces in which patients can discuss sexual behaviors without the fear of stigma.

 

Read out more at: http://www.eurekaselect.com/164166 

Open Access Articles | Sexual Roles, Risk Sexual Behaviours, and HIV Prevalence among Men who Have Sex with Men Seeking HIV Testing in Changsha, China

Journal Name: Current HIV Research

Author(s): Yunxiao Lei, Kaili Zhang, Xueling Xiao, Chulei Tang, Xianhong Li, Honghong Wang*.

Graphical Abstract:

Abstract:

Background: HIV infection is prevalent among men who have sex with men (MSM), and sexual roles may be important factors related to it. This study aims to describe the sexual roles, risky sexual behaviors and HIV prevalence among MSM, and to determine associated factors for HIV prevalence.

Methods: A convenient sampling method was used to recruit participants in a non-government organization in Changsha, China. The participants were asked to complete a 38-item self-administered questionnaire regarding demographic characteristics and risky sexual behaviours before collecting blood samples for HIV testing. Chi-square tests and logistic regression analysis were conducted with the Statistical Package for the Social Sciences Version 18.0 and other indexes were statistically described.

Results: A total of 601 MSMs who came to a local non-government organization for voluntary counseling and testing completed a pencil-and-paper survey and were tested for HIV. The overall HIV prevalence of this sample was 13.3%, and that of the bottoms (16.3%) was similar to the versatiles (15.9%) but higher than the tops (6.1%). Bivariate analyses showed that there were significant differences in age, marital status, monthly income, sexual orientation, age at first sex, sex of the first sex partner, sex with a woman in the last 6 months, oral sex with a man in the last 6 months and role of oral sex among 3 subgroups of MSM (p < 0.05). Multivariate analyses indicated that MSMs who played the role of either the bottoms or the versatiles were more likely to be HIV positive than the tops. While MSMs who used condoms in anal sex in the last 6 months, had sex with a woman in the last 6 months or had oral sex with a man in the last 6 months were less likely to be HIV positive.

Conclusion: Different sexual roles are associated with high-risk sexual behaviors among MSMs and their HIV infection status. Further research should target preventive interventions, and improve the effectiveness of the intervention according to the characteristics of the subgroups to reduce the HIV transmission among Chinese MSM.

 

Read out more at: http://www.eurekaselect.com/163672

ARTICLE BY DISEASE – Anal Cancer: Focus on HIV-Positive Patients in the HAART Era

ARTICLE BY DISEASE ON “ANAL CANCER”

 

 

Abstract:

Anal cancer represents an increasing health problem, especially in immune-compromised patients, as HIVpositive patients. Notably, a significant higher incidence rate is reported among HIV infected patients with the advent of highly active antiretroviral therapy (HAART). To date, no randomised trial supports the correlation between existing screening strategies and reduced progression of anal intraepithelial neoplasia (AIN) to anal cancer or improved survival. Nevertheless, screening and treatment of AIN by topical agents should be implemented in high risk population. Data on invasive anal cancer treatment show that combined modality treatment (CMT) is the treatment of choice. Early reports on HIV-positive patients describe higher treatment toxicity and a relation with lower CD4 count and higher HIV viral load. More recently, reported outcomes seem to be similar in HIV-positive population and general population. Reports on a rise in local recurrence rates and in acute side effects along with a correlation with pre-treatment CD4 counts in HIV-positive patients, are not confirmed by all authors. The development of the first approved vaccine is a milestone in the field of anogenital cancers. However, many questions are still unresolved especially as concerns immunization in the setting of HIV infection.

 

 

For more details, please visit: http://www.eurekaselect.com/node/94357/article

 

 

New Issue :: Current HIV Research Volume 15, Issue 6

Current HIV Research covers all the latest and outstanding developments of HIV research by publishing original research, review articles and guest edited thematic issues. The novel pioneering work in the basic and clinical fields on all areas of HIV research covers: virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, social and public health issues related to HIV disease, and prevention of viral infection. Periodically, the journal invites guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.

chivr

 

Articles from the journal Current HIV Research Volume 15, Issue 6:

                           For details on the articles, please visit this link :: http://bit.ly/2DMLbwS

 

RECENTLY PUBLISHED ISSUES – BENTHAM SCIENCE JOURNALS

Micro and Nanosystems 9-1

http://bit.ly/2zjvQR5

Protein & Peptide Letters 24-9

http://bit.ly/2jcmBcM

Current Medicinal Chemistry 24-34

http://bit.ly/2Cy6zBE

Drug Metabolism Letters 11-1

http://bit.ly/2BuviHQ

Current Medicinal Chemistry 24-35

http://bit.ly/2BDqzWE

Recent Patents on Anti-Cancer Drug Discovery 12-4

http://bit.ly/2jbBv2I

Current Topics in Medicinal Chemistry 17-28

http://bit.ly/2BrEgFr

Current Traditional Medicine 3-3

http://bit.ly/2ySDhLT

Current Protein & Peptide Science 19-1

http://bit.ly/2B8evNJ

Current HIV Research 15-5

http://bit.ly/2kcvDHJ

recent-issues

 

WISHING A VERY HAPPY BIRTHDAY TO DR. CHARLES WOOD!

Tisk

DR. CHARLES WOOD

EDITOR-IN-CHIEF: Current HIV Research

University of Nebraska
Lincoln, NE
USA

%d bloggers like this: